Sirona Biochem Initiates Private Placement
VANCOUVER, British Columbia, Jan. 26, 2024 (GLOBE NEWSWIRE) — Sirona Biochem Corp. (TSX-V:SBM) (FSE: ZSB) (OTC: SRBCF) (the “Company”) is pleased to announce a non-brokered private placement of up to 10,000,000 units of the Company at a price of $0.10 CAD per Unit (a “Unit”) for gross proceeds of up to CAD$1,000,000 (the “Private Placement”). Each Unit consists of one common share and one transferable share purchase warrant, each whole warrant exercisable into one additional common share of the Company for a period of 2 years from the date of issue at a price of $0.15 per Share in year one and $0.25 per Share in year two.
Related news for (SRBCF)
- Sirona Biochem Announces Debenture Financing
- Sirona Biochem Secures Strategic Investment Agreements and New Joint Venture with Promura GmbH
- Sirona Biochem Showcases TFC-1326 in Stonegate Healthcare’s Landmark Report
- GlycoProteMim Featured in Stonegate Healthcare’s Latest Anti-Aging Research Report
- SIRONA BIOCHEM Corporate Update April 2024